2021. November 30., Tuesday

coley_dij_nyito_20211105

Katalin Karikó and Three Fellow Researchers to Receive the William B. Coley Award for mRNA Technology Key to Cancer Treatment

Katalin Karikó, Uğur Sahin, Özlem Türeci and Drew Weissman will receive the 2021 William B. Coley Award for Distinguished Research in Basic Immunology, as announced by the US-based Cancer Research Institute (CRI). According to the institute, the technology associated with the developers of the mRNA vaccine that curbed the COVID-19 pandemic, “this technology will play a big role in cancer treatment”. The William B. Coley Award will be presented to the four researchers during a virtual ceremony that will take place on November 10.

The Cancer Research Institute (CRI) is a non-profit organisation dedicated to harnessing the immune system’s power to control and potentially cure all types of cancer. The William B. Coley Award for outstanding research in basic immunology will be given to four key scientists responsible for the discovery and development of the messenger RNA (mRNA) vaccine against COVID-19, CRI announced on 4 November 2021 in New York.


CRI will present the prestigious 2021 Coley Awards to Katalin Karikó, Ph.D., of the Perelman School of Medicine at the University of Pennsylvania and BioNTech, and Drew Weissman, M.D., Ph.D., of the Perelman School of Medicine at the University of Pennsylvania along with BioNTech co-founders Ugur Sahin, M.D., Ph.D., and Özlem Türeci, M.D., Ph.D., during a virtual ceremony to take place on November 10. During this virtual awards ceremony— called “Future Look: How COVID-19 Vaccines Are Accelerating New Cancer Treatments” – the four researchers will take part in an historic joint interview moderated by TIME science and medicine writer Alice Park.


„Many attendees likely will be surprised to learn that the mRNA technology that changed lives during the current COVID-19 pandemic originated years ago in research intended to combat cancer” said Jill O’Donnell-Tormey, Ph.D., chief executive officer and director of scientific affairs at CRI, explaining the organization’s award decision. „And just as importantly for millions of patients, mRNA will play a big role in cancer treatment going forward." The Cancer Research Institute (CRI) expects to accelerate cancer immunotherapy and vaccine development following the extraordinary validation of mRNA against COVID-19.


The Cancer Research Institute established this award in 1975 in honor of Dr. William B. Coley, now regarded as the Father of Cancer Immunotherapy, whose daughter Helen Coley Nauts (1907-2001) founded the Cancer Research Institute. In the US, the Coley Prize is considered a predictor of the Lasker Prize and the Nobel Prize. To date, it has been given to 115 immunologists and tumor immunologists including the 2021 recipients.


The first prize was awarded in 1975 to a group of 16 scientists considered to be the "founders of cancer immunology". This group includes, among others, Hungarian-born Éva Klein (Fischer) and her husband György Klein. The Klein couple specialised in cancer research at the Swedish Karolinska Institute. Many researchers, who have been awarded the William B. Coley Prize, are also Nobel Prize-winning scientists. One of them is Sir Gregory Winter, whom Katalin Karikó met and had discussions with in Cambridge a few days ago.


For more information about Dr. Katalin Karikó, Honorary Doctor and Alumnus of the University of Szeged, please visit the SZTE news portal or the website of the SZTE Klebelsberg Library.


Article written by: Ilona Újszászi

Translated by: Rita Csúri-Magosi

SZTE Experience

90907094_596440817611266_2395556591035219968_o

Ahmad Adha - Faculty of Humanities and Social Sciences

I am Ahmad Adha from Indonesia and currently a 3rd year student in Theoretical Linguistics PhD program. I chose the University of Szeged (SZTE) as my study destination because it is located in the center of the town and it is also the highest ranked university in Hungary. The university staff and the professors were very accommodating and understanding when I decided to change the program that suits my research topic. I am so glad that I can be a part of my current department, and of course SZTE, since it is also the Center of Pragmatic Research which aims to promote advanced linguistic pragmatic research with international collaborations. After graduating, I wish to continue to work in my academic field as a professor and a researcher. My advice for prospective SZTE students is to choose a university with a good academic reputation that fits their passion.

 

92282474_603497833572231_146210006834872320_o

Hamza Baniata – Faculty of Science and Informatics

I am Hamza Baniata, a first-year student at the Doctoral School of Computer Science, and I am From Jordan. SZTE is continuously supporting research and it has an internationally recognized, highly ranked group of professors. It also offers courses and research topics that are strongly related to my research field; Cloud Computing, Fog Computing and Internet of Things. All of this motivated me to apply to the University/Department of Software Engineering. Szeged is a calm city, full of love and peace. The University of Szeged is similar to the city, which provides the perfect environment for creation and development. Studying at the university requires a high level of effort, commitment and seriousness. Applying to the university and having these characteristics are my two pieces of advice to prospective students. It is very early to define my future now, but I am planning to apply to a research position in my field after graduation and if I had the opportunity, I would love to contribute my effort and knowledge in advancing such a wonderful and respected university.


More...